factual

Drug development is genuinely expensive and risky

Bringing a new cancer drug to market costs an estimated $750 million to several billion dollars because efficacy must usually be shown in large randomized controlled trials, many promising drugs fail that test, companies run multiple trials to ensure one succeeds, and differing FDA and European endpoints force larger trials; this high cost is a legitimate reason a high price is needed as an incentive.

factualpending

Speaker

Vincent Rajkumar

Evidence Quote

“it's just very expensive to develop a new drug. So, I grant that, if you are going to invest in such a high-risk proposition, you should have some way of making that money back”

Source

Vincent Rajkumar on the High Price of Cancer Drugs— EconTalk
Created: 6/13/2026, 12:13:30 AM

Your notes

Loading notes...